Pathology consultation on myeloproliferative neoplasms

Amy E. Schmidt, Stephen T. Oh

Research output: Contribution to journalArticle

2 Scopus citations

Abstract

In 2008, the World Health Organization (WHO) revised the classification system for myeloproliferative neoplasms (MPNs). MPNs include chronic myelogenous leukemia, essential thrombocythemia, polycythemia vera, primary myelofibrosis, and several other disorders. The newer classification system incorporates mutations discovered in the JAK2 and MPL genes. The importance of understanding the role of mutations in JAK2, MPL, and other genes that have been discovered in MPNs is highlighted by the change in the 2008 WHO MPN classification system. Moreover, the development of highly specific inhibitors of JAK2 further stresses the importance of molecular testing in MPN diagnosis and prognosis.

Original languageEnglish
Pages (from-to)12-19
Number of pages8
JournalAmerican journal of clinical pathology
Volume138
Issue number1
DOIs
StatePublished - Jul 1 2012

Keywords

  • Essential thrombocythemia
  • JAK2
  • MPL
  • Myeloproliferative neoplasm
  • Polycythemia vera
  • Primary myelofibrosis

Fingerprint Dive into the research topics of 'Pathology consultation on myeloproliferative neoplasms'. Together they form a unique fingerprint.

Cite this